WO2008142483A3 - Vaccine compositions and methods of use thereof - Google Patents

Vaccine compositions and methods of use thereof Download PDF

Info

Publication number
WO2008142483A3
WO2008142483A3 PCT/IB2007/004614 IB2007004614W WO2008142483A3 WO 2008142483 A3 WO2008142483 A3 WO 2008142483A3 IB 2007004614 W IB2007004614 W IB 2007004614W WO 2008142483 A3 WO2008142483 A3 WO 2008142483A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
vaccine compositions
immunization
compositions
present
Prior art date
Application number
PCT/IB2007/004614
Other languages
French (fr)
Other versions
WO2008142483A2 (en
Inventor
Gerard J A Rouwendal
Original Assignee
Iq Corp Bv
Gerard J A Rouwendal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Iq Corp Bv, Gerard J A Rouwendal filed Critical Iq Corp Bv
Publication of WO2008142483A2 publication Critical patent/WO2008142483A2/en
Publication of WO2008142483A3 publication Critical patent/WO2008142483A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6056—Antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6087—Polysaccharides; Lipopolysaccharides [LPS]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention provides vaccine compositions and methods for immunization.
PCT/IB2007/004614 2006-12-14 2007-12-14 Vaccine compositions and methods of use thereof WO2008142483A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86992606P 2006-12-14 2006-12-14
US60/869,926 2006-12-14

Publications (2)

Publication Number Publication Date
WO2008142483A2 WO2008142483A2 (en) 2008-11-27
WO2008142483A3 true WO2008142483A3 (en) 2009-04-02

Family

ID=40032227

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/004614 WO2008142483A2 (en) 2006-12-14 2007-12-14 Vaccine compositions and methods of use thereof

Country Status (1)

Country Link
WO (1) WO2008142483A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2490707B1 (en) * 2009-10-21 2016-07-27 ETH Zurich Medical utility of glycan-binding proteins and glycans

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153871A2 (en) * 1984-03-01 1985-09-04 Centocor, Inc. Antibody enhancement of immunogenicity of antigen
WO1997035884A1 (en) * 1996-03-27 1997-10-02 The Binding Site Limited Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
WO2007073567A2 (en) * 2005-12-22 2007-06-28 Iq Corporation Compositions and methods of modulating the immune response

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153871A2 (en) * 1984-03-01 1985-09-04 Centocor, Inc. Antibody enhancement of immunogenicity of antigen
WO1997035884A1 (en) * 1996-03-27 1997-10-02 The Binding Site Limited Improved production of antibodies through the use of combinations of antigen and antibody, test kits incorporating said antibodies, and medical uses of said antibodies
WO2007073567A2 (en) * 2005-12-22 2007-06-28 Iq Corporation Compositions and methods of modulating the immune response

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARDOR MURIEL ET AL: "Immunoreactivity in mammals of two typical plant glyco-epitopes, core alpha(1,3)-fucose and core xylose.", GLYCOBIOLOGY, vol. 13, no. 6, June 2003 (2003-06-01), pages 427 - 434, XP002511668, ISSN: 0959-6658 *
FAYE L ET AL: "Affinity Purification of Antibodies Specific for Asn-Linked Glycans Containing alpha1 -> 3 Fucose or beta1 -> 2 Xylose", ANALYTICAL BIOCHEMISTRY, ACADEMIC PRESS INC. NEW YORK, vol. 209, no. 1, 15 February 1993 (1993-02-15), pages 104 - 108, XP024763726, ISSN: 0003-2697, [retrieved on 19930215] *
WEN Y ET AL: "ENHANCED IMMUNOGENICITY IN MICE WITH HEPATITIS B VACCINE COMPLEXED TO HUMAN HEPATITIS B IMMUNOGLOBULIN", CHINESE MEDICAL JOURNAL / ZHONGHUA YIXUE ZAZHI YINGWEN BAN, CHINESE MEDICAL ASSOCIATION, BEIJING, CN, vol. 107, no. 10, 1 January 1994 (1994-01-01), pages 741 - 744, XP002940345, ISSN: 0366-6999 *

Also Published As

Publication number Publication date
WO2008142483A2 (en) 2008-11-27

Similar Documents

Publication Publication Date Title
WO2007130697A8 (en) Anti-ephb4 antibodies and methods using same
WO2008100805A3 (en) Anti-robo4 antibodies and uses therefor
WO2008060705A8 (en) Anti-dll4 antibodies and methods using same
WO2007127834A3 (en) Compositions and methods of preparation thereof
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
WO2011031896A3 (en) Pi3 kinase inhibitors and uses thereof
PH12015500550A1 (en) Anti-notch1 nrr antibodies and methods using same
WO2007133290A3 (en) Anti-ox40l antibodies and methods using same
WO2008127290A3 (en) Alginate and alginate lyase compositions and methods of use
EP1984405A4 (en) Influenza antigens, vaccine compositions, and related methods
WO2008127226A3 (en) P13 kinase antagonists
WO2006091722A3 (en) Alkyl-glycoside enhanced vaccination
WO2011072099A3 (en) Compositions and methods comprising protease variants
WO2007124090A3 (en) Lyophilized therapeutic peptibody formulations
WO2008121767A3 (en) Stitched polypeptides
UA97502C2 (en) Crystalline solid basis of rasagilin
WO2011002808A8 (en) Hcv protease inhibitors and uses thereof
WO2008057550A3 (en) Stabilization of vaccines by lyophilization
WO2005082020A8 (en) Flavivirus vaccines
WO2007127506A3 (en) Anti-ephrinb2 antibodies and methods using same
WO2008025015A8 (en) Epitope-protein scaffolds and their use
WO2008112192A3 (en) Epha3 antibodies for the treatment of solid tumors
IL193392A0 (en) Influenza antibodies, compositions, and related methods
WO2008054481A3 (en) Improved inactivated influenza virus compositions
WO2007106915A3 (en) Antibodies to egfl7 and methods for their use

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07874034

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 07874034

Country of ref document: EP

Kind code of ref document: A2